Lifecare ASA

AGM Information • Sep 17, 2024

MINUTES FROM EXTRAORDINARY GENERAL MEETING

The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid meeting on 17 September 2024.

All proposals on the agenda were adopted, cf. the notification of the Extraordinary General Meeting that was published on Oslo Stock Exchange on 3 September 2024. The complete minutes of the Extraordinary General Meeting are attached and will be available on https://lifecare.no/investor-relations/

About us

Lifecare ASA is a clinical stage medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's main focus is to bring the next generation of Continuous Glucose Monitoring ("CGM") systems to market. Lifecare enables osmotic pressure as sensing principle, combined with the ability to manipulate Nano-granular Tunnelling Resistive sensors ("NTR") on the sensor body for read-out of pressure variations. Lifecare's sensor technology is referred to as "Sencell" and is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication at 2024-09-17 11:00 CEST.

Attachments

2024 09 17 Extraordinary General Meeting Minutes V1